Bronchogen
Bronchogen
Description
A bioregulator peptide targeting lung and respiratory health. Supports bronchial tissue regeneration and respiratory function as part of longevity protocols.
Overview
Bronchogen is a bioregulatory peptide with targeted effects on lung tissues. It is reported to enhance respiratory epithelium, boost surfactant production, and mitigate lung inflammation. Studies in rat models suggest it can alleviate inflammation and restore lung health.
Mechanism of Action
Bronchogen influences DNA transcription pathways, regulating expression of genes like NKX2-1, SCGB1A1, SCGB3A2, FOXA1, and FOXA2. It may bind deoxyribooligonucleotides containing CNG sequences (targets for cytosine DNA methylation), potentially affecting gene regulation.
Benefits
- •Lung health
- •Respiratory support
- •Tissue regeneration
- •Longevity
Dosing Notes
Research protocols vary. A commonly cited injectable schedule is 500 mcg/day subcutaneously in the evening for 40 days; oral capsule schedules of 1-2 capsules 1-2x daily for 20-30 days followed by a multi-month break are also described.
Reported Side Effects
- •Limited human safety data
- •Possible injection site reactions
Safety Notes
Bronchogen is intended for laboratory research use only.
Scientific References
Related Bioregulator Peptides
Vesugen
Vesugen
A vascular bioregulator peptide supporting blood vessel health and circulation. Important for cardiovascular longevity.
2 mgLivagen
Livagen
A liver bioregulator peptide supporting hepatic tissue regeneration and function. Essential for metabolic and detoxification health.
2 mgChonluten
Chonluten
A respiratory bioregulator peptide supporting bronchial mucosa and lung function. Part of comprehensive respiratory health protocols.
2 mgPancragen
Pancragen
A pancreatic bioregulator peptide supporting pancreatic tissue health and metabolic function. Important for blood sugar regulation.
2 mg